Cross-talk between NO and HMGB1 in lymphocytic thyroiditis and papillary thyroid cancer

Oncology Reports

Volumn 24, Issue 6, 2010, Pages 1455-1461

  Mardente, Stefania ^a   Zicari, Alessandra ^a   Consorti, Fabrizio ^a   Mari, Emanuela ^a   Di Vito, Maura ^a   Leopizzi, Martina ^a   Della Rocca, Carlo ^a   Antonaci, Alfredo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

High mobility group box 1; Nitric oxide; Papillary cancer; Thyroiditis

Indexed keywords

BETA ACTIN; CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE;

ADULT; ANGIOGENESIS; ARTICLE; AUTOIMMUNE DISEASE; CANCER INVASION; CANCER RISK; CANCER SUSCEPTIBILITY; CELL TRANSFORMATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATORY INFILTRATE; LYMPHOCYTIC THYROIDITIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; MICROENVIRONMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYROID PAPILLARY CARCINOMA;

EID: 78649402245     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00001005     Document Type: Article

References (24)

1. Antonaci A, Consorti F, Mardente S, Natalizi S, Giovannone G and Della Rocca C: Survivin and cyclin D1 are jointly expressed in thyroid papillary carcinoma and microcarcinoma. Oncol Rep 20: 63-67, 2008.
2. Antonaci A, Consorti F, Mardente S and Giovannone G: Clinical and biological relationship between chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Oncol Res 17: 495-503, 2009.
3. Mardente S, Lenti L, Lococo E, Consorti F, Della Rocca C, Romeo S, Misasi R and Antonaci A: Phenotypic and functional characterization of lymphocytes in autoimmune thyroiditis and in papillary carcinoma. Anticancer Res 25: 2483-2488, 2005.
4. Lala PK and Orucevic A: Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev 17: 91-106, 1998. (Pubitemid 28194648)
5. Arif S, Blanes A and Diaz-Cano SJ: Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma. Histopathology 41: 357-362, 2002.
6. Jaiswal M, La Russo NF, Burgart LJ and Gores GJ: Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 60: 184-190, 2000. (Pubitemid 30058750)
7. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop- Bailey D, Croxtall J and Willoughby DA: Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci 91: 2046-2050, 1994.
8. Nose F, Ichikawa T, Fujiwara M and Okayasu I: Up-regulation of cyclooxygenase-2 expression in lymphocytic thyroiditis and thyroid tumours: significant correlation with inducible nitric oxide synthase. Am J Clin Pathol 117: 546-551, 2002. (Pubitemid 34823683)
9. Kuniyasu H, Yano S, Sasaki T, Sasahira T, Sone S and Ohmori H: Colon cancer cell-derived high mobility group 1/ amphoterin induces growth inhibition and apoptosis in macrophages. Am J Pathol 166: 751-760, 2005.
10. Anderson UG and Tracey KJ: HMGB1, a pro-inflammatory cytokine of clinical interest: introduction. J Intern Med 255: 318-319, 2008.
11. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and Ben-Neriah Y: NF-κB functions as a tumor promoter in inflammation-associated cancer. Nature 431: 461-466, 2004.
12. Kundu KJ and Surh YJ: Inflammation: gearing the journey to cancer. Mutat Res 659: 15-30, 2008.
13. Bhatia A, Rajwanshi A, Dash RJ, Mittal BR and Saxena AK: Lymphocytic thyroiditis: is cytological grading significant? A correlation of grades with clinical, biochemical, ultrasonographic parameters. Cytojournal 4: 10, 2007.
14. Papotti M, Rodriguez J, De Pompa R, Bartolazzi A and Rosai J: Galectin-3 and HBME-1 expression in well differentiated thyroid tumors with follicular architecture of uncertain malignant potential. Mod Pathol 18: 541-546, 2005.
15. Ticconi C, Zicari A, Losardo A, Pontieri G, Pasetto N and Piccione E: Nitric oxide in human fetal membranes at term gestation: effect on prostaglandin E2 release. Eur J Obstet Gynecol Reprod Biol 69: 135-139, 1996.
16. Gupta S, Patel A, Folstad A, Fenton C, Dinauer CA, Tuttle RM, Conran R and Francis GL: Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. J Clin Endocrinol Metab 86: 1346-1354, 2001.
17. Tamimi DM: The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol 10: 10141-10146, 2002.
18. Souza SL, Montalli Da Assumpcao LV and Ward LS: Impact of previous thyroid autoimmune diseases on prognosis of patients with well-differentiated thyroid cancer. Thyroid 13: 491-495, 2003.
19. Orucevic A, Bechberger J, Green AM, Shapiro RA, Billiar TR and Lala PK: Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int J Cancer 81: 889-896, 1999.
20. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop- Bailey D, Croxtall J and Willoughby DA: Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci 91: 2046-2050, 1994.
21. Bianchi M: HMGB1 loves company. J Leukocyte Biol 86: 573-576, 2009.
22. Mantovani A, Marchesi F, Portal C, Allavena P and Sica A: Linking inflammation reactions to cancer: novel targets for therapeutic strategies. Adv Exp Med Biol 610: 112-127, 2008.
23. Sica A, Allavena P and Mantovani A: Cancer related inflammation: the macrophage connection. Cancer Lett 267: 204-215, 2008.
24. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P and Mantovani A: Macrophage polarization in tumour progression. Semin Cancer Biol 18: 349-355, 2008.